![Induction of different cell death characteristics by Triapine and Me 2... | Download Scientific Diagram Induction of different cell death characteristics by Triapine and Me 2... | Download Scientific Diagram](https://www.researchgate.net/publication/328288151/figure/fig4/AS:682001103331329@1539613142147/nduction-of-different-cell-death-characteristics-by-Triapine-and-Me-2-NNMe-2-a-Cell.png)
Induction of different cell death characteristics by Triapine and Me 2... | Download Scientific Diagram
Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer | PLOS ONE
![Triapine | CAS:236392-56-6 | Ribonucleotide reductase inhibitor | High Purity | Manufacturer BioCrick Triapine | CAS:236392-56-6 | Ribonucleotide reductase inhibitor | High Purity | Manufacturer BioCrick](https://www.biocrick.com/media/images/struct3D/BCC5112.png)
Triapine | CAS:236392-56-6 | Ribonucleotide reductase inhibitor | High Purity | Manufacturer BioCrick
Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer | PLOS ONE
![Impact of Stepwise NH2-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance Circumvention | Journal of Medicinal Chemistry Impact of Stepwise NH2-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance Circumvention | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.6b00342/asset/images/large/jm-2016-003422_0008.jpeg)
Impact of Stepwise NH2-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance Circumvention | Journal of Medicinal Chemistry
![Frontiers | Phase I Trial of Triapine–Cisplatin–Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers Frontiers | Phase I Trial of Triapine–Cisplatin–Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers](https://www.frontiersin.org/files/Articles/240305/fonc-07-00062-HTML/image_m/fonc-07-00062-g001.jpg)
Frontiers | Phase I Trial of Triapine–Cisplatin–Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers
![Frontiers | Phase I Trial of Triapine–Cisplatin–Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers Frontiers | Phase I Trial of Triapine–Cisplatin–Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers](https://www.frontiersin.org/files/Articles/240305/fonc-07-00062-HTML/image_m/fonc-07-00062-t001.jpg)
Frontiers | Phase I Trial of Triapine–Cisplatin–Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers
![Biomolecules | Free Full-Text | Triapine Derivatives Act as Copper Delivery Vehicles to Induce Deadly Metal Overload in Cancer Cells | HTML Biomolecules | Free Full-Text | Triapine Derivatives Act as Copper Delivery Vehicles to Induce Deadly Metal Overload in Cancer Cells | HTML](https://www.mdpi.com/biomolecules/biomolecules-10-01336/article_deploy/html/images/biomolecules-10-01336-ag.png)
Biomolecules | Free Full-Text | Triapine Derivatives Act as Copper Delivery Vehicles to Induce Deadly Metal Overload in Cancer Cells | HTML
![Current and Future Initiatives for Radiation Oncology at the National Cancer Institute in the Era of Precision Medicine - International Journal of Radiation Oncology, Biology, Physics Current and Future Initiatives for Radiation Oncology at the National Cancer Institute in the Era of Precision Medicine - International Journal of Radiation Oncology, Biology, Physics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/01ce5ec6-0e13-4efc-bcc8-2ee1936e9393/gr1_lrg.jpg)
Current and Future Initiatives for Radiation Oncology at the National Cancer Institute in the Era of Precision Medicine - International Journal of Radiation Oncology, Biology, Physics
![Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair | British Journal of Cancer Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fbjc.2016.54/MediaObjects/41416_2016_Article_BFbjc201654_Fig5_HTML.jpg)
Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair | British Journal of Cancer
![Clinical Trial: Triapine and Lutetium Lu 177 Dotatate for Neuroendocrine Tumors – Ronny Allan – Living with Neuroendocrine Cancer Clinical Trial: Triapine and Lutetium Lu 177 Dotatate for Neuroendocrine Tumors – Ronny Allan – Living with Neuroendocrine Cancer](https://i0.wp.com/ronnyallan.net/wp-content/uploads/2022/06/Clinical-Trial-Triapine-and-prrt.jpg?fit=1280%2C720&ssl=1)
Clinical Trial: Triapine and Lutetium Lu 177 Dotatate for Neuroendocrine Tumors – Ronny Allan – Living with Neuroendocrine Cancer
![Triapine | CAS:236392-56-6 | Ribonucleotide reductase inhibitor | High Purity | Manufacturer BioCrick Triapine | CAS:236392-56-6 | Ribonucleotide reductase inhibitor | High Purity | Manufacturer BioCrick](https://www.biocrick.com/media/images/struct/BCC5112.png)
Triapine | CAS:236392-56-6 | Ribonucleotide reductase inhibitor | High Purity | Manufacturer BioCrick
Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition | Inorganic Chemistry
![Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs | SpringerLink Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00775-019-01675-0/MediaObjects/775_2019_1675_Figa_HTML.png)
Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs | SpringerLink
![Pharmacological Targeting of the Integrated Protein Kinase B, Phosphatase and Tensin Homolog Deleted on Chromosome 10, and Transforming Growth Factor-β Pathways in Prostate Cancer | Molecular Pharmacology Pharmacological Targeting of the Integrated Protein Kinase B, Phosphatase and Tensin Homolog Deleted on Chromosome 10, and Transforming Growth Factor-β Pathways in Prostate Cancer | Molecular Pharmacology](https://molpharm.aspetjournals.org/content/molpharm/75/3/429/F3.large.jpg)
Pharmacological Targeting of the Integrated Protein Kinase B, Phosphatase and Tensin Homolog Deleted on Chromosome 10, and Transforming Growth Factor-β Pathways in Prostate Cancer | Molecular Pharmacology
![The anticancer thiosemicarbazones Dp44mT and triapine lack inhibitory effects as catalytic inhibitors or poisons of DNA topoisomerase IIα - ScienceDirect The anticancer thiosemicarbazones Dp44mT and triapine lack inhibitory effects as catalytic inhibitors or poisons of DNA topoisomerase IIα - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295212002377-fx1.jpg)
The anticancer thiosemicarbazones Dp44mT and triapine lack inhibitory effects as catalytic inhibitors or poisons of DNA topoisomerase IIα - ScienceDirect
![Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs | SpringerLink Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00775-019-01675-0/MediaObjects/775_2019_1675_Fig1_HTML.png)
Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs | SpringerLink
![Determination of triapine, a ribonucleotide reductase inhibitor, in human plasma by liquid chromatography tandem mass spectrometry - Feng - 2015 - Biomedical Chromatography - Wiley Online Library Determination of triapine, a ribonucleotide reductase inhibitor, in human plasma by liquid chromatography tandem mass spectrometry - Feng - 2015 - Biomedical Chromatography - Wiley Online Library](https://analyticalsciencejournals.onlinelibrary.wiley.com/cms/asset/ddaac778-dfd5-4de5-97f2-c9768c2bd6e1/bmc3434-fig-0001-m.jpg)